BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Bifidobacterium animalis subsp. lactis {B. Lactis} - Lactobacillus panisapium |
👶
Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut (Gut ) Vol: 51 Issue 1 Pages: 51-5 Pub: 2002 Jul Epub: Authors Kirjavainen PV , Arvola T , Salminen SJ , Isolauri E , Html Article Publication |
| Bifidobacterium animalis subsp. lactis {B. Lactis} - Lactobacillus panisapium |
👶
Amelioration of inflammatory bowel disease by Bifidobacterium animalis subsp. lactis XLTG11 in combination with mesalazine. Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1472776 Pub: 2024 Epub: 2024 Dec 4 Authors Ma W , Wu Y , Lin X , Yang L , Huang L , Html Article Publication |
| Bifidobacterium animalis subsp. lactis {B. Lactis} - Lactobacillus panisapium |
👶
Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial. Medicine (Medicine (Baltimore) ) Vol: 103 Issue 21 Pages: e37883 Pub: 2024 May 24 Epub: Authors Tian Y , Wu G , Zhao X , Zhang H , Ren M , Song X , Chang H , Jing Z , Html Article Publication |
| Bifidobacterium animalis subsp. lactis {B. Lactis} - Lactobacillus panisapium |
👶
Bifidobacterium improves oestrogen-deficiency-induced osteoporosis in mice by modulating intestinal immunity. Food & function (Food Funct ) Vol: 15 Issue 4 Pages: 1840-1851 Pub: 2024 Feb 19 Epub: 2024 Feb 19 Authors Zhang J , Liang X , Tian X , Zhao M , Mu Y , Yi H , Zhang Z , Zhang L , Publication |
| Bifidobacterium animalis subsp. lactis {B. Lactis} - Lactobacillus panisapium |
👶
Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21 Pub: 2015 Apr Epub: Authors Shadnoush M , Hosseini RS , Khalilnezhad A , Navai L , Goudarzi H , Vaezjalali M , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
